The US Department of Justice has launched an investigation into the sales and marketing of a drug approved three years ago to help treat Parkinson's patients suffering from debilitating psychosis.
The drug's maker, Acadia Pharmaceuticals, disclosed the investigation in filings with the Securities and Exchange Commission. Citing a desperate need for a seriously ill population, the Food and Drug Administration approved Nuplazid in 2016 despite a conclusion from the government's medical reviewer that the benefits of the antipsychotic medication didn't outweigh its risks.It is the only drug on the market approved to combat hallucinations and delusions in Parkinson's patients.
The US Department of Justice has launched an game of clue into the sales and marketing of a drug approved three years ago to help treat Parkinson's patients suffering from debilitating psychosis
POTUS
Where were they over the past 3 yrs?
Wow CNN calling out the Obama admin
How about investigations on all drug makers and congress!? All drug makers and congress are millionaires!!! Off the people!!!
Click on the link to read it a fourth time.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: politico - 🏆 381. / 59 Read more »